The ICTMG activities are primarily managed through two types of projects: "Guideline Development Group (GDG)" projects and "Implementation and Dissemination" projects.

​

All projects are led by a minimum of one ICTMG Full Member and may include Full Members and Project Members in their teams. "GDG" projects bring together clinical, methodology experts and patients to develop or update an ICTMG guideline. "Implementation and Dissemination" projects are brought together to develop resources and activities to facilitate the dissemination and implementation of ICTMG guidelines.

​

Full Members and Project Members can join a Project by completing the online Project Application Form.

​

ICTMG Guideline Development Group projects

​

FNAIT Guideline Development Group project (guideline updates)

Status: Recruiting

Co-chairs (Project Leads): Lani Lieberman and TBD

Objective: Review the new evidence since ICTMG guideline publication and make updates as needed.

Project team: Recruiting

Start date:  Early 2024

End date:  TBD

Learn more about this ICTMG guideline and resources.

​

Hemoglobinopathies Guideline Development Group project (guideline updates)

Status: Ongoing

Co-chairs (Project Leads): Julia Wolf and Isabelle Blais-Normandin

Objective: Review the new evidence since ICTMG guideline publication and make updates as needed.

Project team: Recruitment completed

Start date: Summer 2022

End date: Early 2024

Learn more about this ICTMG guideline and resources.

​

Albumin Use Guideline Development Group project (new guideline)

Status: Submitted for publication

Co-chairs (Project Leads): Jeannie Callum and Nikolas Skubas

Objective: Develop evidence-based recommendations for the use of intravenous albumin in pediatric and adult patients requiring critical care support, undergoing cardiovascular surgery, undergoing kidney replacement therapy or experiencing complications from cirrhosis.

Learn more about this ICTMG guideline and resources. 

​

Hemolytic Disease of the Newborn (HDN) Guideline Development Group project (new guidelines)

Status: Completed

Co-chairs (Project Leads): Lani Lieberman and Enrico Lopriore

Objective: Develop evidence-based recommendations regarding the effectiveness and safety of IVIG to reduce the need for exchange transfusions, improve neurocognitive outcomes, reduce bilirubin level, reduce the frequency of red blood cell transfusions and severity of anemia, and/or reduce duration of hospitalization for neonates with Rh or ABO-mediated HDN.

Learn more about this ICTMG guideline and resources.

​

Platelet Guideline Development Group project (new guidelines)

Status: Ongoing

Co-chairs (Project Leads): Susan Nahirniak and Simon Stanworth

Objective: Develop evidence-based recommendation for the use of platelets in thrombocytopenic patients.

Project team: Recruitment completed

Start date: May 2018

End date: Summer 2024 (TBC)

Learn more about this ICTMG guideline and resources. (Content is in development and will be available shortly.)

​

ICTMG Dissemination and Implementation projects

​

ICTMG Website Management project

Project Lead(s): Recruiting

Objective: Develop and update ICTMG.org content.

Project team: Recruiting

Start date: Spring 2023

End date: TBD

​

Hemolytic Disease of the Newborn (HDN) Knowledge Mobilization project

Status:  Completed

Project Lead(s): Abby Wolfe and Sophie Chargé

Objective: Develop resources to increase awareness and facilitate implementation of the ICTMG HDN guideline.

Learn more about this ICTMG guideline and resources. 

​

Albumin Use Knowledge Mobilization project

Project Lead(s): Recruiting

Objective: Develop resources to increase awareness and facilitate implementation of the ICTMG Albumin guideline.

Project team: Recruiting

Start date: Early 2024

End date: TBD

Learn more about this ICTMG guideline and resources.

​